4592

SanBio
4592

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
¥136.68B
EV
¥134.16B
Shares Outstanding
72.01M
Beta
-0.08

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
¥1320.00
P/E 2026E
-
P/Revenue 2026E
87.25x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About SanBio Company Limited

gainify
4592

SanBio Company Limited

4592

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipelin...

Sector

Healthcare

Industry

Biotechnology

CEO

Mori, Keita

Employees

29

IPO Date

2015-04-08

Headquarters

St. Luke Tower, 13th Floor, 8-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved